Aswe, Elizer R.
HRN: 14-53-45 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/27/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
08/27/2024
09/03/2024
IV
4.5gms
Q6
Hepatic Abscess
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes